
Melodiol Global Health Ltd
ASX:ME1

Intrinsic Value
The intrinsic value of one
ME1
stock under the Base Case scenario is
0.055
AUD.
Compared to the current market price of 0.001 AUD,
Melodiol Global Health Ltd
is
Undervalued by 98%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Melodiol Global Health Ltd
Balance Sheet Decomposition
Melodiol Global Health Ltd
Current Assets | 5.5m |
Cash & Short-Term Investments | 692k |
Receivables | 3m |
Other Current Assets | 1.9m |
Non-Current Assets | 13.5m |
PP&E | 9.7m |
Intangibles | 3.6m |
Other Non-Current Assets | 274k |
Free Cash Flow Analysis
Melodiol Global Health Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Melodiol Global Health Ltd
Revenue
|
19.6m
AUD
|
Cost of Revenue
|
-16.6m
AUD
|
Gross Profit
|
3m
AUD
|
Operating Expenses
|
-19.3m
AUD
|
Operating Income
|
-16.3m
AUD
|
Other Expenses
|
-36.2m
AUD
|
Net Income
|
-52.4m
AUD
|
ME1 Profitability Score
Profitability Due Diligence
Melodiol Global Health Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Score
Melodiol Global Health Ltd's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
ME1 Solvency Score
Solvency Due Diligence
Melodiol Global Health Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Score
Melodiol Global Health Ltd's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ME1 Price Targets Summary
Melodiol Global Health Ltd
Dividends
Current shareholder yield for ME1 is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?